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The genetic basis underlying how organisms adapt to different environments and evolve new life 
style is a central issue of molecular evolution. The evolution of aerobic fermentation in yeasts is 
one of those good examples. So far the underlying genetic basis of this phenotypic evolution 
remains unclear. Gene duplication, as a primary source of materials for evolutionary novelties, 
has long been thought to play an important role in the adaptation of organisms to their 
environments. It was hypothesized that whole genome duplication (WGD) led to the 
development of this efficient fermentative life style. However, it remains unclear how the WGD 
genes are regulated during the switch of energy metabolism, an issue which should be the 
essence of the “WGD-Fermentation hypothesis”. 
 
In this study, I first used a genome-wide expression dataset during robust metabolic oscillation in 
response to oxygen in budding yeast (Tu et al. 2005) to investigate the distribution of WGD 
genes in metabolic cycle. An enrichment of WGD genes was found underlying the physiological 
response of S. cerevisiae to oxygen change. Our results provided new evidence for the 
WGD-Fermentation hypothesis. In the next, I explored in more detail about what were the 
important WGD genes that contributed greatly to the evolution of aerobic fermentation. Two 
WGD genes are brought to the front to study this issue due to their importance on regulating 
energy metabolism.  
 
  
One of the two genes is pyruvate kinase (PYK), and the other is the target of rapamycin (TOR). 
In both cases, I revealed positive correlations between the copy number of these genes and the 
strength of aerobic fermentation on a yeast phylogenetic tree, which implies that gene 
duplication events of PYK and TOR are possible to facilitate the evolution of aerobic 
fermentation. In the PYK experiment, I found that yeasts with higher capabilities on the 
allosteric regulation of PYK tend to have higher fermentation abilities. I then assumed that the 
strengthened allosteric regulation of PYK after gene duplication might be important in the 
development of fermentation lifestyle in yeast. Further study on T403E mutant which is defect in 
allosteric regulation on PYK supported this assumption, as T403E mutant showed raised 
oxidative phosphorylation and decreased fermentation rate compared with the control. In the 
TOR experiment, I mimicked the TOR gene duplication during yeast history and doubled the 
TOR gene in a Crabtree-negative yeast K.lactis. I observed that the fermentation ratio in the 
doubled TOR mutant was significantly increased compared with the control, which supported 
that TOR gene duplication contributed greatly to the evolution of fermentative life style. In the 
view of the similar features shared by fermenting yeast and cancer cells on aerobic fermentation, 
our studies on PYK and TOR may shed lights on the mechanism how the Warburg effect is 
regulated in tumor cells.  
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Introduction for aerobic fermentation and gene duplication 
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1.1. Aerobic fermentation in yeast 
The evolution of aerobic fermentation in yeasts is a good example of phenotypic evolution. In 
eukaryotes, glucose is mainly assimilated through the respiration pathway in mitochondria to 
produce CO2 and H2O for maximum energy yield in the presence of oxygen. However, some 
yeast such as Saccharomyces cerevisiae undergo aerobic fermentation in which glucose is 
predominantly fermented to ethanol even in the presence of oxygen. Those are called as 
Crabtree-positive yeasts (1). In fact, fermenting yeasts grow at higher rates compared to those 
that grow oxidatively (2). These yeasts are subjected to fluctuations of nutrient availability in 
their natural environment, thus, must be able to successfully adapt their metabolism in order to 
meet the energy demand and survive.  
 
In a glucose-rich environment, fermentation is their main metabolic pathway for carbon and 
energy metabolism. In contrast, when a non-fermentable carbon source such as glycerol, ethanol 
or lactate is present, respiration will be the main energy-yielding pathway (3).  If glucose is 
added during yeast aerobic growth, they immediately arrest respiration and accelerate glycolysis 
at the same time that ethanol is produced (4). This phenomenon is called as Crabtree effect. The 
transition is modulated by short-term and long-term events. The latter involves the 
down-regulation of gluconeogenic and oxidative metabolism-related proteins and the enhanced 
transcription of glycolytic enzymes and glucose transporters (5, 6). Recent studies indicated that 
the evolution of aerobic fermentation in the Saccharomyces cerevisiae lineage was associated 
with regulatory reprogramming of genes involved in respiration and mitochondrial functions (7, 
 3 
8). The loss of a specific cis-regulatory element in many genes coding for mitochondrial proteins 
in the Saccharomyces cerevisiae lineage was speculated to have contributed to the transcriptional 
reprogramming process (7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 4 
1. 2. Tumor cell metabolism: The Warburg effect 
One of the major differences observed between cancer cells and normal cells is in how they 
metabolize glucose; most cancer cells primarily metabolize glucose by glycolysis, most normal 
cells completely catabolize glucose by oxidative phosphorylation (9). The phenomenon in tumor 
cells, as described as even in the presence of a normal oxygen level, glycolysis is highly elevated 
and accompanied by high lactate production as well as drastically reduced mitochondrial 
respiration, is termed as “the Warburg effect” (10-12). As a matter of fact, aerobic glycolysis is 
an inefficient way to generate adenosine 5’-triphosphate (ATP); however, the advantage it 
confers to cancer cells has been unclear. It is probable that this phenotype endows tumor cells 
with some advantages in order to survive and proliferate in harsh microenvironments, such as in 
hypoxic conditions and within poorly vascularized tumors (13). This metabolic adaptation could 
also help malignant cells to overcome programmed cell death mechanisms (14). For some tumor 
cells a correlation between invasiveness and their glycolytic capacity was observed (15, 16). It is 
also reported that this shift to aerobic glycolysis with lactate production, coupled with increased 
glucose uptake, is likely used by proliferating cells to promote the efficient conversion of 
glucose into the macromolecules needed to construct a new cell (17). 
 
The molecular mechanisms underlying the “Warburg effect” are still unknown. Nevertheless, it 
is possible that the enhanced expression of glycolysis enzymes and glucose transporters along 
with a down-regulation of mitochondrial metabolism could be at the basis of the glycolytic 
phenotype of tumor cells (10). In that case, the hypoxia-induced metabolic reprogramming 
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mediated by the HIF-1 transcription factor has been pointed out as the key regulator for 
the“aerobic glycolysis” in tumors, as the expression of glycolysis enzymes, glucose transporters 
and several other tumor-related genes are controlled by HIF-1 (18). It is also proposed that 
Warburg effect appears as consequence of an irreversible damage to mitochondria and to the 
proteins involved in oxidative metabolism (10). Some recent studies do suggest that many 
cancers have mitochondrial DNA mutations, which might result in dysfunctional mitochondria 
and promote glycolysis (19, 20). However, this hypothesis was met with significant skepticism 
specifically because some tumors do not have defects in respiration (21-23). In particular, 
Chance et al. (24, 25) found that ascites tumor cells used by Warburg had in fact, higher 
respiration than cardiac or yeast mitochondria. From these observations it was construed that 
respiratory deficiency could not be the cause of high glycolytic rates, despite the observations 
that many cancer cells do indeed have morphologically abnormal mitochondria. There might be 
other mechanisms underlying the “aerobic glycolysis” in cancer cell.  
 
Since the “aerobic glycolysis” is considered the paradigm of tumor cell metabolism, it seems 
reasonable that some features of tumor aerobic glycolysis can actually be used as a marker for 
cancer diagnosis, and disruption of glycolysis might be a promising candidate for specific 
anti-cancer therapy. The fluorodeoxyglucose-based positron emission tomography (FDG-PET 
scan) is widely employed for these purposes. This technique is based on the increased capacity of 
tumor cells for glucose uptake, thus facilitating the identification of tumors and potentially 
malignant overgrowths (26). Some studies show that the tumor cell lines are more sensitive to 
 6 
oxidative phosphorylation-inhibiting drugs than their normal counterparts (21). While other 
study also reported that the chemical dichloroacetic acid (DCA), which promotes respiration and 
the activity of mitochondria, has been shown to kill cancer cells in vitro and in some animal 
models (27). Therefore, it is important to fully understand the Warburg effect in order to gain 
insight into the mechanisms of tumor cell energy conversion processes. This will improve the 
establishment of specific therapies for successful cancer treatment.  
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1. 3. Metabolic similarities between tumor cells and fermenting yeast 
Yeast is a good model for studying Warburg effect in cancer cells. First of all, the fermenting 
yeast Saccharomyces cerevisiae has proven a valuable model organism in which several 
intracellular processes have been characterized in great detail. And from a metabolic point of 
view, Saccharomyces cerevisiae and tumor cells share several features. In both cell types, there 
are mechanisms that enhance glycolytic flux concomitantly with the repression of oxidative 
phosphorylation, and fermentation is preferred even in the presence of oxygen.  
 
Hexokinase (HK), phosphofructokinase (PFK) and pyruvate kinase (PK) are considered the main 
controlling steps for glycolysis flux modulation as they catalyze the three irreversible reactions 
in the glycolytic sequence (28). Indeed, an overexpression and/or overactivation of these three 
enzymes have been described for a number of tumor cells and in yeast (Figure 1.1) (29-31).  
 
Warburg originally hypothesized that in addition to glycolysis acceleration there is an 
irreversible damage to mitochondria in tumor cells as the origin of “aerobic glycolysis” (10). 
This seems to be correct for some tumors. For instance, deficiencies in complex I are linked with 
tumor cell progression and metastasis in lung carcinoma and fibrosarcoma cell lines (32). 
ComplexII and IV activities decrease in some hepatoma cell lines regarding normal hepatocytes 
(33). Likewise, tricarboxylic acid (TCA) cycle down-regulation has also been identified in 
fermenting yeast. In these conditions the enzymatic activities of aconitase, isocitrate 
dehydrogenase and malate dehydrogenase are decreased (34). The activity of the mitochondrial 
 8 
respiratory complexes II and IV is also lower in fermentation. This may originate by negative 
regulation at the transcriptional level (30, 34). 
 
In view of these similarities and given the fact that Saccharomyces cerevisiae display a Crabtree 
effect, thus providing a good model for studying the Warburg effect. Besides that, this yeast is an 
easy-to-use experimental model; there is possibility of the utilization of yeast as a tool for testing 
anti-tumor drugs for metabolic therapy (35). Another advantage is the existence of yeasts that are 
classified as Crabtree-negative (such as Kluyveromyces lactis and Candida albicans) (1). Hence, 
the identification of the differences between both kinds of yeast may provide some insight into 
the mechanism leading to Crabtree effect. 
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Figure 1.1 Metabolic similarities between yeast and tumor cells. Hexokinase (HK) isoforms 
insensitive to glucose 6-phosphate-mediated inhibition are overexpressed. Phosphofructokinase 
(PFK) is activated by higher levels of one of its allosteric activators: fructose 2,6-biphosphate 
(F26BP). The mainly isoform of Pyruvate kinase (PK) is strongly activate by fructose 
1,6-biphosphate (F16BP). The enzymes that metabolize pyruvate in the cell cytoplasm are 
overexpressed: Lactate dehydrogenase (LDH) in the case of cancer cells and pyruvate 
decarboxylase in yeast (PDC). In both cases, a decreased expression of mitochondrial complex 
IV is observed as well as a down-regulation of the ATP synthase. 
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1.4. Whole genome duplication (WGD) and aerobic fermentation 
Genomic duplication has been proposed as an advantageous path to evolutionary innovation, 
because duplicated genes can supply genetic raw material for the emergence of new functions 
through the forces of mutation and natural selection. Such duplication can involve individual 
genes, genomic segments or whole genomes. Direct study of such a cataclysmic genomic event 
may provide major insights into the dynamics of genome evolution and the emergence of new 
functions. 
 
Whole-genome duplication (WGD) in yeast, estimated to have occurred in the ancestor of the 
Saccharomyces sensu stricto species complex around 100 million years ago (Mya) (36-39), has 
been proposed to have led to the evolution of an efficient fermentation system in this lineage 
(40-42). This hypothesis was supported by various observations. One study indicates that with 
plentiful glucose, most post-WGD yeast species primarily carry out fermentation to generate 
energy even under aerobic conditions (Crabtree-positive); while in contrast, pre-WGD yeast 
species mostly respire under such conditions (1). Several authors have speculated that WGD 
enhanced S. cerevisiae’s ability to metabolize glucose (43-45) and/or to grow anaerobically (40, 
41, 46). There is also evidence that the preservation of some duplicate gene pairs created by the 
WGD was related to their contribution toward high glycolytic flux (47). And more WGD genes 
than non-WGD genes are found to be dynamically regulated during metabolic oscillation in 
response to oxygen change (48).  
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Besides these observations, some studies have recently identified the genetic changes that 
occurred in ancient yeast progenitors to provide a foundation for the development of efficient 
fermentation. Ihmels et al. (7) indicates that the loss of a specific cis-regulatory element from 
dozens of genes following the apparent WGD event rewires the transcriptional network of yeast, 
thus connected to the emergence of the capacity for rapid fermentation growth. A study on the 
nuclear-encoded mitochondrial genes between post- and pre-WGD species also suggests that 
relaxation of yeast mitochondrial functions could occur in the relevant yeast species after 
whole-genome duplication (49).  
 
All the above studies are inspiring. However, in order to explore in detail the mechanism 
underlying the evolution of aerobic fermentation, studying individual pair of duplicate genes is 
necessary to reveal a concrete picture of the mechanism. Thomson et al. (50) proved that several 
duplicate genes especially Adh1-Adh2 duplication, along with the ability of S. cerevisiae and its 
closest relatives to ferment glucose and accumulate ethanol even in the presence of oxygen, 
formed the basis for the ‘make-accumulate-consume’ strategy of ethanol production, which 
provided the ancestor of Saccharomyces yeast with an advantage over its competitors because 
ethanol is toxic to most other microbes. A recent study provided evidence that hexose transporter 
(HXT) gene duplication has facilitated the evolution of aerobic fermentation (51), thus 
emphasize the first step of glucose metabolism of transporting glucose across the plasma 
membrane in this mechanism. Therefore, in our studies, I focused on two potential duplicates: 
the gene of yeast pyruvate kinase (PYK) and the gene of target of rapamycin (TOR).  
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1.5. Aerobic fermentation related WGD genes 
 
1.5.1. Pyruvate kinase  
Pyruvate kinase catalyzes the dephosphorylation of phosphoenolpyruvate (PEP) to pyruvate and 
is responsible for net ATP production within the glycolytic sequence. In contrast to 
mitochondrial respiration, ATP regeneration by pyruvate kinase is independent of oxygen supply 
and allows the survival of organs under hypoxic conditions. 
 
In yeast, there are two isoforms of pyruvate kinase (Pyk1 and Pyk2). Pyk1 can be strongly 
up-regulated by fructose 1,6-biphosphate (F1,6BP) (52), and it seems to be expressed 
constitutively, although its levels are much higher during fermentation (53). Pyk2 is less 
sensitive towards F1,6BP and its expression seems to be repressed by glucose (52). So, the 
presence of only isoform 1 during fermentation could be interpreted as an adaptation that leads to 
the complete activation of the enzyme and hence allows a maximal glycolytic flux. 
 
In mammals, four isoforms of this enzyme exist as L-, R-, M1- or M2, which are tissue-specific 
and differ in their kinetic properties. Pyruvate kinase type L (PKL) is the characteristic pyruvate 
kinase isoenzyme of tissues with gluconeogenesis such as liver and kidney. Erythrocytes express 
the pyruvate kinase isoenzyme type R (PKR). Pyruvate kinase type M1 (PKM1) is present in 
tissues in which large amounts of energy have to be rapidly provided such as in muscle and brain. 
Pyruvate kinase type M2 (PKM2) is characteristic of lung tissues as well as all cells with high 
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rates of nucleic acid synthesis, including all proliferating cells such as embryonic cells, adult 
stem cells and especially tumor cells (54-59). Pyruvate kinase isoenzymes type L and R are 
encoded by the same gene, but are under the control of different promoters. Pyruvate kinase 
isoenzymes type M1 and M2 are different splicing products of the same mRNA transcript and 
differ in 21 amino acids (55, 60).  
 
S. Mazurek et al. (61) documented a role for PKM2 in tumor metabolism by demonstrating that 
the more active tetrameric PKM2 favors glycolysis and lactate production, whereas the less 
active dimeric form predominantly found in cancer cells favors the diversion of trioses toward 
synthetic processes such as lipid and amino acid biosynthesis. The tetramer:dimer ratio is not a 
stationary value, but rather oscillates between the tetrameric and dimeric forms of PKM2 and 
this oscillation is regulated by the intracellular F1,6BP concentrations. When the F1,6BP levels 
reach a certain high value, the inactive dimeric form re-associates to form the highly active 
tetrameric form (62, 63). In contrast, PKM1 is insensitive to F1,6BP regulation (64).  Christofk 
et al. (65) reported that replacement of PKM2 by PKM1 in tumor cell lines rendered them less 
glycolytically active and diminished tumor xenograft growth, which suggests that PKM2 is 
responsible for the Warburg effect. In order to further explore the role of PKM2 in tumor cell 
metabolism, one study found that F1,6BP, the positive allosteric regulator of PKM2, could be 
released from tetrameric PKM2 by interaction with specific tyrosine-phosphorylated peptides, 
including that of LDHA, resulting in the less active dimeric form of PKM2 (66). Hence, 
regulation of PKM2 seems to be pivotal for regulating glycolysis in proliferating cells. Another 
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recent study showed PKM2 inhibitor that disrupted the regulation of F1,6BP could result in 
decreased glycolysis and increased cell death following loss of growth factor signaling in cancer 
cells (67), which in further emphasize the importance of PKM2 regulation in Warburg effect. 
 
1.5.2. Target of rapamycin 
The target of rapamycin (TOR) is a large (281kDa) conserved Ser/Thr protein kinase that 
functions as a central controller of cell growth in response to environmental cues. In 1991, two 
TOR isoforms named TOR1 and TOR2 which share 67% sequence were identified in budding 
yeast Saccharomyces cerevisiae through analysis of resistant mutants to rapamycin, an 
immunosuppressive and potential anticancer drug (68, 69). Two TOR orthologs have also been 
isolated from fission yeast Schizosaccharomyces pombe (70). Unlike yeast, which in some cases 
possess two TOR genes, higher eukaryotes possess only a single TOR gene (mTOR in mammals), 
highly conserved with yeast TOR1 and TOR2 (40%–60% identity) (71, 72).  
 
In vivo, TOR is associated with two distinct multiprotein complexes: TOR complex 1 (TORC1) 
and TOR complex 2 (TORC2). Yeast TORC1 comprises either TOR1 or TOR2 bound to KOG1, 
LST8, and Tco89, whereas yeast TORC2 is formed from TOR2, AVO1, AVO1, AVO3, LST8, 
and Bit61 (73). KOG1 and AVO3 (the homologs of which are Raptor and Rictor in mammals, 
respectively) confer distinctive structural and functional features on TORC1 and TORC2.  
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TORC1 is activated by growth factors, stress, nutrients, and energy signals to regulate cell 
growth. It mediates the rapamycin-sensitive signaling branch that positively regulates anabolic 
processes such as transcription, translation, and ribosome biogenesis and negatively regulates 
catabolic processes such as autophagy and other degradative pathways (72). TORC2 signaling is 
rapamycin-insensitive and is required for the organization of the actin cytoskeleton (74). In cells 
of higher eukaryotes, a heterodimer of the tuberous sclerosis proteins TSC1 and TSC2 regulates 
TOR signaling negatively (75). TSC2 functions as a GTPase activating protein (GAP) for the 
small GTPase Rheb, which is necessary to elevate the kinase activity of TORC1 (76). Therefore, 
inactivation of TSC2 could increase TORC1 activity. Curiously, however, budding yeast does not 
have homologs to the TSC genes, and the loss of RHEB (the homolog of mammalian Rheb) has 
no obvious effect on the cell cycle progression in this microbe (77).  
 
Various alterations of the proto-oncogenes and tumor suppressors along mTOR signaling 
pathway mark this network as one of the most frequently dysregulated signaling cascades in 
cancers (78-81). To this end, rapamycin and its analogs which inhibit mTOR are currently being 
evaluated in clinical trials as cancer treatments (82, 83). mTOR integrates a broad spectrum of 
input, ranging from growth factor signaling to cellular nutrient status to energy supply, for 
regulation of protein synthesis and cell growth (84, 85). Even though the downstream events of 
oncogenic mTOR leading to cancer development are still largely unknown, among numerous 
mTOR effectors, the proto-oncogene Myc family and hypoxia-inducible factors (HIFs) are often 
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activated in various cancers and have been considered an “axis of evil” in cancer development 
(86-89). Although the function of normal c-Myc is inhibited by physiological HIF1α signaling, 
oncogenic Myc and HIFs collaborate with each other to confer metabolic advantages to cancer 
cells by induction of the Warburg effect through transcriptional activation of glycolytic enzymes 
(90). Another protein Akt, an important upstream effector of mTOR, is also proven to stimulate 
aerobic glycolysis in cancer cells (91). Some recent studies provided evidences to support that 
mTOR was a major positive regulator of the Warburg effect, as increased mTOR activity is 
coupled with enhanced lactate production (92, 93). While other studies proposed conflict results 
that inhibiting mTOR functions in cancer cells enhanced aerobic glycolysis and decreased 
uncoupled mitochondrial respiration (94, 95). Xu et al. (2005) showed that targeting mTOR 
pathway in combination with inhibition of glycolysis would synergistically impact the energy 
metabolism in cancer cells and achieve better therapeutic outcomes to kill malignant cells (96), 
which may suggest that mTOR pathway impact cancer cell metabolism through a different 
strategy other than glycolysis. Therefore, it is necessary to further study whether mTOR 
contributes to aerobic fermentation directly, which can help better understand how mTOR is 
involved in cancer related metabolisms.   
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CHAPTER TWO 
 
 
 
 
Regulation dynamics of WGD genes during yeast metabolic oscillation 
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2. 1. Summary 
 
Saccharomyces cerevisiae and its close relatives are characterized by their ability to ferment even 
in the presence of oxygen. It was hypothesized that whole genome duplication (WGD) led to the 
development of this efficient fermentative life style (WGD-Fermentation hypothesis, Piskur, 
2001). In this study, I found that a significantly higher proportion of WGD genes than non-WGD 
genes are dynamically regulated during metabolic oscillation in response to oxygen change. The 
same dataset also shows that the WGD genes, as compared to the smaller-scale duplicate (SSD) 
genes, are enriched with pairs where both copies have cyclic expression during the metabolic 
oscillation (either with the same or different phases). These results provide new evidences for the 
WGD-Fermentation hypothesis and new insights into the relationship between genome 
duplication and the evolution of new life styles in eukaryotic organisms.  
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2. 2. Introduction 
 
Gene duplication, as a primary source of materials for evolutionary novelties, had long been 
thought to play an important role in the adaptation of organisms to their environments (1-3). 
Models that aim to explain the retention of duplicate genes include subfunctionalization (4, 5), 
neofunctionalization (1) and selection for high dosage (6, 7). Baker’s yeast S. cerevisiae and its 
close relatives owe their competitiveness to a combination of several properties including fast 
growth with or without oxygen, efficient glucose repression of respiration genes, and good 
ability to produce and consume ethanol (8). It was proposed that the whole genome duplication 
(WGD) that occurred about 100 million years ago in this lineage (9-12) might have provided the 
basis for specialization of a number of duplicate genes, enabling their optimal functions in either 
aerobic or anaerobic conditions, and thus providing a competitive advantage for the "new" 
Saccharomyces group (13).  
 
This “WGD-Fermentation hypothesis” was supported by various observations. A recent study 
indicates that the ability to grow anaerobically on minimal media and the presence of a Crabtree 
effect are strongly associated with yeasts possessing the WGD (14). Another study found a 
general trend for higher rates of ethanol production in post-WGD yeasts than in non-WGD yeasts 
(15). There are also evidences indicating that many retained WGD genes could contribute to 
yeast’s ability to ferment glucose anaerobically (16), and that glycolytic flux was increased as an 
outcome of WGD (17). These studies are inspiring; nevertheless, it remains unclear how the 
WGD genes are regulated between aerobic and anaerobic metabolisms, an issue which should be 
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the essence of the “WGD-Fermentation hypothesis”. 
 
Based on this hypothesis, I would expect an enrichment of WGD genes underlying the 
physiological response of S. cerevisiae to oxygen change. A recent work investigating 
genome-wide expression during a robust metabolic oscillation in budding yeast provides an 
opportunity to test our prediction (18). During the metabolic oscillation, many parameters – such 
as respiration rate, ethanol production and dissolved oxygen concentration in the media – change 
periodically, so each cycle could be characterized by a respiratory phase followed by an ethanol 
fermentative phase (19). The genes that exhibit periodic expression patterns during the metabolic 
oscillation should be closely related to the physiological regulation between aerobic and 
anaerobic metabolisms. Using this dataset, I am able to show that WGD genes tend to have more 
dynamic regulation than non-WGD genes during the oscillation, indicating possible functional 
specialization of the WGD genes in either respiratory or fermentative stages. Our results provide 
new evidences for the “WGD-Fermentation hypothesis”.
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2. 3. Result 
 
2. 3. 1. Distribution of WGD and non-WGD genes in the metabolic cycle 
The genes exhibiting periodic expression patterns during the metabolic oscillation are called 
metabolic cycling genes (18). I compared 1,108 WGD and 5,101 non-WGD genes to test 
whether WGD genes were more likely to have cycling expression pattern than the other genes in 
the genome. As a result, 722 WGD and 2,777 non-WGD genes were identified as metabolic 
cycling genes (Table 2.1). The proportion of metabolic cycling genes was significantly higher for 
the WGD genes than that for the non-WGD genes (P≤0.0001, Fisher's exact test). Ribosomal 
protein genes (RPs) are commonly retained after WGD (110 out of 137 RPs are WGD genes) and 
most of them cycle during the metabolic oscillation. Thus, to exclude the possibility that the 
result above was caused by RPs, I removed them from the data set and redid the analysis; the 
result remained the same (Table 2.1). 
 
2. 3. 2. Distribution of WGD and non-WGD genes in different expression profiles 
There are four possible expression profiles for duplicate gene pairs during the metabolic 
oscillation (Figure 2.1). The expression profile where two copies have the same cycle (Figure 
2.1A) suggests that dosage effect might be important for keeping both genes working together in 
the same condition. Indeed, most of the RP duplicates have this expression pattern. The 
expression profile where two copies cycle differently (Figure 2.1B) may indicate 
subfunctionalization, neofunctionalization, or a combination of the two events (20) in which case  
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Table 2.1 Distribution of WGD and non-WGD genes in the metabolic cycle. 
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  Number of cycling 
genes 
Number of non-cycling 
genes Ratio 
All genes 
 
WGD genes 
 
722 
 
386 1.87 
Non-WGD 
genes 
 
2,777 
 
2,324 1.19 
Excluding ribosomal protein and spurious genes 
 
WGD genes 
 
595 
 
313 1.90 
Non-WGD 
genes 
 
2,383 
 
1,864 1.28 
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Figure 2.1. Examples of different expression profiles of duplicate genes during metabolic 
oscillation. A. Two genes have the same cycle; B. Two genes cycle differently; C. One gene 
cycles and the other does not; D. Both genes do not cycle. 
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two duplicate genes have divergent functions in aerobic and anaerobic metabolic conditions. The 
regulation divergence could facilitate the functional optimization of duplicate genes in individual 
condition. Both expression profiles could provide competitive advantage for organisms during 
adaptation to the new fermentative lifestyle. On the other hand, the duplicate gene pairs with 
expression profiles where only one duplicate copy cycles (Figure 2.1C) or where both copies do 
not cycle (Figure 2.1D) might be functionally less relevant to the evolution of efficient 
fermentation.  
 
After comparing the expression profiles for 554 WGD duplicate pairs (21) and 1,636 
smaller-scale duplicate (SSD) ones (22), I found a significantly higher proportion of the WGD 
duplicate genes than the SSD ones with pattern A and B (P≤0.0001 Fisher’s exact test), while the 
gene pairs with the other two expression patterns show opposite trends (Figure 2.2), suggesting 
dosage effect and functional specialization related with aerobic and anaerobic metabolisms might 
be important in keeping both duplicate genes after the WGD. The results provide evidence that 
the WGD event greatly contributed to the fermentative lifestyle, since more WGD genes, rather 
than SSD genes, are preferentially retained with the selective function of increasing the 
organism's ability to regulate its metabolism in response to oxygen change. 
 
2. 3. 3. Distribution of WGD genes among functional categories 
It has been reported that WGD genes have unique functional distributions when compared with 
the rest of the genome (22). Using the new dataset, I confirmed the previous results (23) that  
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Figure 2.2. The proportions of WGD and non-WGD genes with different expression profiles. (A. 
B. C. D. as indicated in Figure 2.1) 
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transcriptional factors were preferentially retained after WGD in yeast (6.22% vs. 2.53% for 
WGD and non-WGD genes, respectively. P<0.0001) (Table 2.2). I also found that the WGD 
metabolic cycling genes are enriched with antioxidant, signal transducer and enzyme regulator 
function (Table 2.3). This functional bias might be important for the yeast’s anaerobic adaptation. 
To grow efficiently at low oxygen levels, high-level fermentative metabolism is essential, which 
involves many active enzyme regulators; moreover, it is essential to maintain the redox balance, 
which may require significant antioxidant activities (8). In addition, diversifying the signal 
pathways by retaining duplicate genes for many signal transducers would be a powerful way to 
increase the regulatory complexity of the yeast under anaerobic conditions (24).  
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Table 2.2. Distribution of transcription factors in WGD and non-WGD genes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 40 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Number of transcription 
factors 
Number of non-transcription 
factors 
WGD genes 69 1,039 
Non-WGD genes 129 4,972 
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Table 2.3. Distribution of all yeast genes and WGD cycling genes among 13 GO functional 
categories. 
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GO functional categories* 
Number of 
yeast genes in 
category 
Number of 
cycling WGD 
genes 
Percent of 
cycling WGD 
genes  
Antioxidant activity 28 12 0.43 
Signal transducer activity 202 57 0.28 
Enzyme regulator activity 253 69 0.27 
Structural molecule activity 337 86 0.26 
Transcription  
regulator activity 394 75 0.19 
Chaperone regulator activity 32 6 0.19 
Translation regulator activity 66 10 0.15 
Ase activity 3,790 552 0.15 
Catalytic activity 605 83 0.14 
Binding 1,295 171 0.13 
Transporter activity 713 83 0.12 
Protein tag 9 1 0.11 
Triplet codon-amino acid 
adaptor activity 45 0 0.00 
 
* The 13 GO functional categories which contain yeast genes are the first level categories under 
the Molecular Function GO part, downloaded on 25/Feb/2007. 
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2. 4. Discussion 
In this study, I found a higher proportion of WGD genes than non-WGD genes are regulated in 
response to oxygen change. In addition, WGD duplicates, as compared to non-WGD pairs, are 
more likely to have cyclic expression during the metabolic oscillation. These results suggest that 
WGD event does contribute greatly to the evolution of efficient fermentation in post-WGD yeast 
species.  
 
I have to emphasize that WGD might not be necessary for all the adaptive properties in a 
fermentative lifestyle. Some pre-WGD yeast species are also capable of facultative fermentation, 
yet none of them are comparable to S. cerevisiae. The fission yeast, S. pombe, which diverged 
from the ancestor of S. cerevisiae much earlier than the WGD, can conduct efficient aerobic 
fermentation. It can also consume ethanol but not as its sole carbon source (25) owing to the 
absence of a complete glyoxylate cycle. K. lactis, which is a poor producer of ethanol, can 
efficiently consume ethanol as its only carbon source. Therefore, it seems these adaptive 
properties are unevenly developed among different yeast lineages. 
 
On the other hand, the WGD event is also not sufficient for fermentative lifestyle development. 
Soil yeast, K. polysporus, cannot carry out efficient fermentation although the organism 
experience WGD during its evolution (26). It was recently reported that K. polysporus and S. 
cerevisiae diverged very soon after the WGD, and that the following gene loss in these two 
clades proceeded completely independently (27). Increased availability of fruit sugars at the end 
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of the Cretaceous period might have provided a selective pressure for the development of 
fermentative ability (9), and the WGD happened to coincide with that event, thus providing a 
possible cause for the evolution of the efficient fermentation in Saccharomyces lineage. However, 
soil yeast K. polysporus, due to its unique living environment, might not be influenced much by 
the abundant fruit sugars, thus evolving in a totally different direction.  
 
It remains unclear whether there were other molecular events that initiated the evolution of 
efficient fermentation in the ancestor of S. cerevisiae after its divergence from K. polysporus. 
Nevertheless, in accordance with previous observations, our results indicate that the WGD event 
could have led to a unique combination of adaptive properties related with efficient fermentation 
in S. cerevisiae and its closest relatives, thus providing new insights into the relationship between 
whole genome duplication and the evolution of new life styles in eukaryotic organisms.  
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2. 5. Experimental Procedures and Methods 
Expression data during the metabolic oscillation were taken from Tu et al. (2005) (18). There are 
three super gene-clusters based on the expression data: Ox (oxidative), R/B (reductive/building) 
and R/C (reductive/charging). Each of these superclusters comprises genes that are periodically 
expressed and peak within a certain window of the yeast metabolic cycle. The 554 WGD pairs 
were from Byrne and Wolfe 2005. The 1,636 SSD pairs were derived from all the yeast’s 
duplicate genes that are not associated with WGD (22). The re-annotated gene list from Wood et 
al (2001) (28) was also used in our analysis. 
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CHAPTER THREE 
 
 
 
 
F1,6BP regulation of pyruvate kinase is involved in mediating yeast aerobic fermentation 
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3. 1. Summary 
The embryonic M2 isoform of pyruvate kinase (PKM2) which express exclusively in tumor cells 
is necessary for the shift in cellular metabolism towards aerobic glycolysis and this promotes 
tumorigenesis. S. cerevisiae pyruvate kinase isoform 1 (PYK1) shares similar features with 
PKM2 as it is also important in yeast fermentation growth when oxygen is present, and both 
genes can be well regulated by D-Fructose-1,6-Bisphosphate (F1,6BP). Here I measure the 
F1,6BP regulation abilities on PYK in 6 yeast species with different fermentation abilities. The 
result indicates that yeasts with higher capabilities on the allosteric regulation of PYK tend to 
have higher fermentation abilities, which indicates the function of F1,6BP regulation on PYK 
might be important in the development of fermentation lifestyle in yeast. A mutant called T403E 
which is defect in F1,6BP regulation shows raised oxidative phosphorylation and decreased 
fermentation rate, as well as an increased lifespan. There results provide new evidences to 
support the critical function of F1,6BP regulation on PYK in aerobic fermentation, which may 
shed lights on the mechanism of PKM2 in Warburg effect. 
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3. 2. Introduction 
Glycolysis and oxidative phosphorylation are primary sources of cellular energy. Pyruvate, the 
end product of glycolysis, is either metabolized through the citrate cycle and respiratory chain or 
fermented to lactate or ethanol. In the first half of the twentieth century, Otto Warburg and his 
coworkers observed that cells switch from oxidative to fermentative metabolism during 
tumorigenesis. Despite the presence of oxygen, most cancer tissue respires with low efficiency 
but has increased glucose consumption and lactate secretion (1-3). Recently, it has become clear 
that this metabolic transition is not specific to cancer cells but rather a common metabolic feature 
of cells that rapidly proliferate. Warburg-like effects have been described in yeast (4), during 
T cell proliferation (5), and upon reprogramming fibroblasts into induced pluripotent stem cells 
(6). 
 
The glycolytic enzyme pyruvate kinase (PYK) which catalyzes the conversion of 
phosphoenolpyruvate (PEP) to pyruvate has been implicated in the regulation of the Warburg 
effect. The low-active splice form of the PKM-type pyruvate kinase (PKM2) is present at higher 
concentration in cancers compared to matched control tissue (7, 8). And it’s regulation by 
D-Fructose-1,6-Bisphosphate (F1,6BP) is confirmed to be important in cancer metabolism and 
tumor growth (8-10). A change to expression of the higher active PKM1 which is insensitive to 
F1,6BP increased respiration and slowed cancer progression in xenograft models (8). Studying 
the problem why PKM2 rather than PKM1 increases aerobic fermentation is critical in 
understanding the Warburg effect, thus improving the establishment of specific therapies for 
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cancer treatment.  
 
A possible explanation is that PKM1 preferentially shuttles pyruvate to the mitochondria or 
PKM2 preferentially shuttles pyruvate to lactate dehydrogenase, as tyrosine phosphorylation of 
lactate dehydrogenase might facilitate its binding to PKM2 (8). Another study indicates there 
could be an alternative glycolytic pathway avoiding PYK step in PKM2-expressing cells, which 
is corresponding mostly to the high lactate production (11). Furthermore, it is reported that 
PKM2 hydroxylation on proline 403/408 stimulates binding and activation of hypoxia-induced 
factor HIF1α, increasing the expression of metabolic enzymes under hypoxia in a PYK 
activity-independent manner (12). However, the mechanism why F1,6BP regulation on PKM2 is 
important in Warburg effect is still unclear. 
 
Some yeasts, like S. cerevisiae, display a Crabtree effect (aerobic fermentation), thus providing a 
good model for studying the phenomenon of Warburg effect. There is also existence of yeasts 
that are classified as Crabtree-negative such as K. lactis. Therefore, the identification of the 
differences between these two kinds of yeast may shed lights on the mechanism leading to 
Crabtree effect. The metabolic features shared between S. cerevisiae and tumors have been 
previously identified (13). S. cerevisiae has two copies of PYK genes which showed similar 
characteristics compared to their homologs in mammal. Like PKM2, S. cerevisiae PYK1 which 
can be well regulated by F1,6BP is dominantly expressed when yeast performs aerobic 
fermentation; while S. cerevisiae PYK2 which is insensitive to F1,6BP has expression when 
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glucose concentration is low and cells start doing respiration, a feature comparable to PKM1 (14, 
15). Here I measured the F1,6BP regulation capabilities on PYK in some representative 
Crabtree-negative and positive yeasts, and showed that this regulation ability might be important 
for crabtree effect. Experiments on a T403E mutant strain which is defect in F1,6BP regulation 
suggested possible mechanisms and advantages for the allosteric regulation of PYK in cells 
which can perform aerobic fermentation. 
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3. 3. Result 
 
3. 3. 1. Distribution of copy number of pyruvate kinase genes in yeast phylogenetic tree 
Many studies supported that the WGD event has led to the evolution of an efficient fermentation 
system in Saccharomyces sensu stricto lineage (16-19). Given that fact that PYK also belongs to 
WGD genes (20) and plays an essential role in glycolysis, I was interested in investigating the 
distribution of PYK gene number in representative fungi species and match these data with 
corresponding fermentation abilities. An interesting association between the copy number of 
PYK genes and the fermentation ability in yeast species was found as shown in Figure 3.1. Most 
post-WGD yeast species having two PYK genes are better fermenters (21) than those pre-WGD 
species with only one PYK gene. One post-WGD yeast K. polysporus which diverged very soon 
after the WGD with S. cerevisiae, cannot carry out efficient fermentation (22) and amazingly just 
kept one PYK gene in its genome, while the other one copy was lost during evolution. Therefore, 
comparing the differences of the characteristics of PYK genes between both kinds of yeast may 
provide some insights into the mechanism by which PYK duplication improved fermentation 
ability in yeast, thus shed light on the role of pyruvate kinase in Warburg effect in tumor cells. 
 
3. 3. 2. F1,6BP regulation of pyruvate kinase in pre- and post-WGD yeast species 
In S. cerevisiae, there are two PYK genes which are WGD duplicates. PYK1 can be positively 
up-regulated by F1,6BP and it seems to have dominant function during fermentation (23, 24);  
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Figure 3.1. Number of PYK genes in clade Saccharomycotina. Arrow indicates the whole 
genome duplication events. Numbers in parenthesis are number of PYK genes in each species. 
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while PYK2 is insensitive towards F1,6BP and it may only work when glucose concentration is 
low and cells switch energy metabolism towards respiration (23). This pattern is quite similar to 
PKM2 and PKM1 in mammals. I therefore studied F1,6BP regulation function of pyruvate 
kinase among three post-WGD yeast species (S. cerevisiae, S. baynus, K. polysporus) and three 
pre-WGD species (K. lactis, S. kluyveri, C. albicans), in order to test the hypothesis that F1,6BP 
regulation of pyruvate kinase contributed greatly to the evolution of aerobic fermentation. 
 
The in vitro pyruvate kinase activity study confirmed previous results that in S. cerevisiae PYK1 
is strongly regulated by F1,6BP; while PYK2 has lower activity and is insensitive to F1,6BP 
regulation. The pyruvate kinase activity in other yeast species showed similar value to S. 
cerevisiae PYK1 when F1,6BP is added, with an exception of S. baynus in which even the 
activity of PYK1 is relatively low. This may result from different intracellular environment 
conditions, such as PEP concentrations.  In addition, S. baynus PYK2 shares the same pattern 
with S. cerevisiae PYK2, as having no regulation of F1,6BP. However, the situation is quite 
different in all yeast species when F1,6BP is absent. As all three post-WGD yeast species nearly 
have no pyruvate kinase activity detected in isoform 1, all three pre-WGD species show 
significant pyruvate kinase activity, even without F1,6BP addition. Interestingly, the pyruvate 
kinase activities without F1,6BP in the three pre-WGD species seem to coordinate with their 
fermentation abilities, as S. kluyveri, the best fermenter among three (21) has the lowest pyruvate 
kinase activity, while C. albicans, which dominantly perform respiration (25), has the highest 
(Figure 3.2A). In order to better understand the extent of F1,6BP regulation of pyruvate kinase in 
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different yeast species, I calculated pyruvate kinase activity ratio (activity with F1,6BP divided 
by w/o F1,6BP) for PYK genes in all yeast species (Figure 3.2B). I can see a clear trend that 
post-WGD species have better F1,6BP regulation ability on PYK (for isoform 1) than pre-WGD 
yeast species.  
 
I then measured the fermentation ratios of all 6 yeast species (Figure 3.2C), and compared them 
with their corresponding pyruvate kinase activity ratio (Figure 3.2B). Fermentation ratio refers to 
ethanol production divided by glucose consumption. For both respiration and fermentation could 
cost glucose while only fermentation would yield ethanol, thus the fermentation ratio could 
represent the fermentation ability of yeast cells. I could see an approximately positive correlation 
between their pyruvate kinase activity ratios and their fermentation abilities, especially for the 
three pre-WGD yeast species, among which this correlation is quite clear. The incoordinated 
parts may have explanations. The fermentation ratio of K. polysporus is even lower than some 
pre-WGD species at beginning. This is consistent with the study that K. polysporus cannot carry 
out efficient fermentation due to a lot of gene loss after WGD (7). In addition, S. kluyveri has 
comparable fermentation ability with some post-WGD species, since although S. kluyveri is a 
petite-negative yeast, it still can grow anaerobically, a big difference from other pre-WGD 
species (26). Therefore, my results may suggest that the F1,6BP regulation on PYK plays an 
importance role on aerobic fermentation in yeast. The duplication of PYK after WGD event may 
experience subfunctionalization as keeping one copy insensitive to F1,6BP and strengthening the 
F1,6BP regulation on the other copy, thus helping most post-WGD species evolve into good 
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Figure 3.2 The ability of F1,6BP regulation on pyruvate kinase is related to corresponding 
yeast’s fermentation ability. (A) The pyruvate kinase activity (U/mg) for 6 yeast species with or 
without 1mM F1,6BP treatment. (B) Pyruvate kinase activity activity ratio derived from Figure 
3.3A. For each PYK gene, this ratio is calculated as activity w/o F1,6BP divided by that with 
1mM F1,6BP. (C) Fermentation ratio at different time points for all 6 yeast species. 
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fermenters. 
 
3. 3. 3. The fermentation ability of a mutant (T403E) which disrupt in F1,6BP regulation of 
pyruvate kinase    
As I observed a positive correlation between the capability of F1,6BP regulation on pyruvate 
kinase and the corresponding yeast’s fermentation ability, I want to further confirm this 
hypothesis within molecular mechanism. A mutant (T403E) with a point mutation in S. 
cerevisiae PYK1, which could block the binding of F1,6BP thereby preventing allosteric 
activation (27), may provide us a good opportunity to study this problem.  
 
In order to get rid of the possible influence of PYK2, I constructed this mutant strain on a PYK2 
deletion background and measured its fermentation ratio along with its wild-type control strain. I 
found that the wild-type strain consumed glucose much quicker and produced more ethanol as 
compared to T403E mutant (Figure 3.3A). This is consistent with the fact that the wild-type 
grows much faster than T403E mutant (data not shown). The fermentation ratio of the wild-type 
strain is also showed to be significantly higher than that of T403E mutant (Figure 3.3B), which 
proves our hypothesis that F1,6BP regulation on pyruvate kinase is important on aerobic 
fermentation, as disruption of this regulation could result in lower fermentation capability. I also 
measured the oxygen consumption of these two strains, and found that the T403E mutant 
consumed more oxygen than wild-type (Figure 3.3C). This result further supports our hypothesis 
and indicates that the disruption of F1,6BP regulation could change the metabolic switch from 
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Figure 3.3. The mutation T403E lowers fermentation and increases respiration. (A) Shown are 
glucose, ethanol concentrations during aerobic batch cultivation of wild-type strain and T403E 
mutant. (B) Fermentation ratio of wild-type strain and T403E mutant during aerobic batch 
culture. (C) The oxygen consumption (mg/ml/107) of wild-type strain and T403E mutant. 
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fermentation to respiration. 
 
3. 3. 4. FBA simulation of pyruvate flux through fermentation    
Flux Balance Analysis (FBA) is a metabolic modeling framework which employs the known 
stoichiometry of a system to simulate metabolism without requiring kinetic parameters or 
assumptions regarding specific fluxes (28-32).  Microbes such as S. cerevisiae have evolved to 
maximize their growth rate; FBA uses a pseudo-reaction with biomass constituents that have 
been experimentally measured as reactants, scaled to the amount need for one gram of biomass 
(dry) so that it represents the growth rate. The growth rate is maximized, allowing us to see the 
activity of pathways used for growth in specific nutritive conditions.  
 
The FBA simulation shows the fraction of pyruvate flux going through pyruvate decarboxylase 
(PyrDC) and the amount of biomass produced as a function of glucose uptake or pyruvate uptake 
when maximizing biomass production (Figure 3.4). PyrDC catalyzes the nonoxidative 
decarboxylation of pyruvate to acetaldehyde, thus leading the pyruvate flux towards fermentation 
(33). I observed that the flux through C rose along with the increase of glucose or pyruvate 
uptake, thus indicating that F1,6BP regulation on pyruvate kinase may influence the fermentation 
flux by controlling pyruvate production.  
 
 
 
 65 
 
 
 
 
 
 
 
 
 
Figure 3.4. The fraction of pyruvate flux going through pyruvate decarboxylase (PyrDC) and the 
amount of biomass produced as a function of glucose uptake or pyruvate uptake when 
maximizing biomass. 
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The simulation also indicates a moderate decrease in pyruvate through PyrDC when growing on 
pyruvate later on. This could be due to an increase in pyruvate flux through alanine 
aminotransferase (ALT1) to synthesize alanine, not other energy metabolic pathways (34). 
 
3. 3. 5. Gene expression profiling of T403E by RNA-seq  
Previous results indicated that the T403E mutant, which is disable in F1,6BP regulation of PYK1, 
may make energy metabolism switch towards respiration by shutting down pyruvate flux. In 
order to prove this assumption and better understand the molecular mechanism change in T403E 
mutant, I employ RNA-seq to compare the transcriptome profiling of this mutant with that of 
wild-type. The Pearson’s correlation between two replicates is quite high in both cases (Figure 
3.5A), which makes the RNA-seq results more convincing. All the up-regulated and 
down-regulated genes in T403E are grouped into different GO function categories respectively. 
The up-regulated genes in T403E are significantly enriched in 22 second level GO terms, among 
which I found several GO terms inspiring: for example, mitochondrion, mitochondrial envelope 
under component category; oxidoreductase activity under function category; cellular respiration 
and response to oxidative stress under process category (Figure 3.5B). This result is consistent 
with previous data that the T403E mutant consumes more oxygen, and provides strong evidence 
to support that the dysfunctional F1,6BP regulation could affect energy metabolism by improving 
respiration. In the meanwhile, I also notice that the down-regulated genes in T403E mutant are 
enriched in ribosome and translation related function categories (Figure 3.5C), which explains 
the slower growth of the T403E mutant (data not shown).  
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Figure 3.5. The functional enrichment of up- and down-regulated genes in T403E strains. (A) 
Pearson’s correlation of two expression profiling replicates for wild-type and T403E mutant 
respectively. The Y axis and X axis are log10 of total reads for each gene in corresponding 
replicate. (B) The X axis denotes the GO terms which showed significant enrichment of 
up-regulated genes in T403E (P-value < 0.01). The Y axis represents the percentage of genes in a 
certain functional category. The orange bars are up-regulated genes in T403E strains and the 
green bars are the percentage of genes at genomic background. (C) Significant enrichment of 
down-regulated genes in T403E (P-value < 0.01). The X and Y axis are similar to Figure 3.5B.  
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3. 3. 6. The life span of T403E is increased compared to wild-type 
It is reported that the shunting of carbon metabolism toward the mitochondrial tricarboxylic acid 
cycle and the concomitant increase in respiration plays a central part in life span extension in 
Saccharomyces cerevisiae during calorie restriction (35, 36). Though there is also contradictory 
study which claimed that calorie restriction in yeast does not require respiration to extend life 
span of mother cells (37), Su-Ju Lin et al. explained that this contradiction was just caused by 
different experimental protocols (38). So far the mechanism by which mitochondrial respiration 
affects yeast life span has not, to my knowledge, been determined to date. Since I uncovered 
increased respiration in T403E mutant, I am interested to further test the chronological life span 
of this mutant and wild-type strains.  
 
As expected, the T403E mutant with higher respiration does have longer life span compared to 
wild-type (Figure 3.6). Therefore, I found new evidence to support that higher respiratory 
activity increases lifespan in yeast. As yeasts evolve aerobic fermentation to be better 
competitive by fast growing and ethanol production, they seem to have a trade-off for these 
advantages by shorting lifespan due to decreased respiration. Therefore, a good regulation ability 
of F1,6BP on PYK1 could be necessary to evolve along with aerobic fermentation, as at high 
glucose concentration, high level of F1,6BP could stimulate PYK1 to maximize pyruvate flux, 
thus facilitating aerobic fermentation to beat other competitors; while glucose is about to 
depleted, PYK1 will be sensitively inactivated due to lack of enough F1,6BP, therefore the 
diminishing pyruvate flux would make energy metabolism switch from fermentation to  
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Figure 3.6. Chronological life span analysis of wild-type and T403E mutant. Average lifespans: 
wild-type, 25.6 days; T403E, 34.3 days. 
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respiration, which is not only more economic at energy production but also keeps the yeasts at 
good status under starving conditions.    
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3. 4. Discussion 
In the present study, I have shown that the duplication of pyruvate kinase gene after WGD event 
provides opportunities to develop a much more sensitive F1,6BP regulation function, which 
facilitating the evolution of aerobic fermentation. The observations in Figure 3.2B are construed 
to suggest that this allosteric regulation function might be largely improved right after the WGD, 
since the PYK of K. polysporus which diverged very soon after the WGD with S. cerevisiae, also 
possess as good F1,6BP regulation ability as S. cerevisiae PYK1, even if K. polysporus cannot 
carry out efficient fermentation (7). This may suggest that the well regulated F1,6BP regulation 
function on PYK is not sufficient for fermentative lifestyle development. However, it is reported 
that although the acquisition by an enzyme of some new regulatory feature may not cause a large 
increase in fitness, it would be retained in evolution whenever it provides a selective advantage 
(39). This explanation may apply to our case.  
 
On the other hand, a sensitive F1,6BP regulation function on pyruvate kinase seems to be 
necessary for efficient aerobic fermentation, which is supported by many recent studies on 
PKM2 in cancer cells (8-10). Christofk et al (8) found that switching pyruvate kinase expression 
to PKM1, which is insensitive to F1,6BP yet more active than PKM2, could lead to reversal of 
the Warburg effect, as judged by reduced lactate production and increased oxygen consumption. 
Another research group showed that a PKM2 mutant Y105F, which elevated PKM2 activity by 
preventing the release of F1,6BP from PKM2, had increased oxygen consumption and decreased 
lactate production relative to H1299 lung cancer cells expressing wild-type PKM2 (9). Our 
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results also indicate that this assumption could be true in yeast since T403E mutant which cannot 
be activated by F1,6BP on PYK1 increases oxidative phosphorylation while decreases its 
fermentation ratio.  
 
It has been reported that low PYK activity could activate yeast respiration (40). In cancer cells, 
knockdown of PKM2 expression also results in reduced glycolysis and decreased cell 
proliferation (10). Our FBA simulation predicted a positive correlation between the amount of 
pyruvate uptake and the flux towards fermentation. Therefore, decreased pyruvate flux caused by 
dysregulation of F1,6BP on PYK1 could be regarded as a possible mechanism leading to 
decreased fermentation ability in T403E mutant. However, studies in cancer cells on PKM2 (8, 9) 
indicate that pyruvate kinase activity is not the determinant reason for the energy metabolism 
change, as pyruvate kinase with elevated activity yet cannot be regulated by F1,6BP still 
decrease lactate production in cells. Our results also show that pre-WGD species like C. albicans 
which cannot conduct efficient fermentation have PYK with high activity even in the lack of 
F1,6BP (Figure 3.2A).  
 
All these results together suggest that F1,6BP regulation on pyruvate kinase is necessary for 
aerobic fermentation. Pyruvate flux changed by dysfunction of F1,6BP regulation might be a 
potential mechanism to influence the switch of energy metabolism but not the determinant 
reason. Other mechanisms caused by F1,6BP regulation on PYK may play more important roles 
on facilitating efficient fermentation, but still need to be explored. One possible explanation why 
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allosteric regulation of PKM2 is important in aerobic fermentation and tumor growth is that the 
less active PKM2 dimer form results in partial inhibition of glycolysis, which accumulates all 
upstream glycolytic intermediates as an anabolic feed for synthesis of lipids and nucleic acids, 
whereas reassociation of PKM2 into active tetramer replenishes the normal catabolism as a 
feedback after cell division (41). Therefore, the regulation of PKM2 activity may allow for a 
balance between ATP production and fatty acid/nucleic acid production. Alternatively, F1,6BP 
regulation of PKM2 enzymatic activity may provide a direct link between cell growth signals 
and control of glycolytic metabolism (42). Our result on T403E life span also suggests that the 
less active form of pyruvate kinase may provide cells with healthier environments which are 
necessary for the fitness of the cells that can perform aerobic fermentation.  
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3. 5. Experimental Procedures and Methods 
Phylogenetic tree of yeast  
This Phylogenetic tree was constructed using the Maximum-Likelihood (ML) method with 1000 
bootstrap replicates by Phyml 2.4 (43) using the ribosome protein gene sequences from 13 fungal 
species.  
 
Cloning of pyruvate kinase genes  
We independently cloned 8 PYK genes onto ppSUMO Kan plasmid. These genes and the 
corresponding cloning primers are S. cerevisiae PYK1 (5’ 
CAGATTGGTGGATCCATGTCTAGATTAGAAAGATT3’ & 5’ 
GTGGTGGTGCTCGAGTTAAACGGTAGAGACTTGCA3’) / PYK2 
(5’CAGATTGGTGGATCCATGCCAGAGTCCAGATTGCA3’ & 5’ 
GTGGTGGTGCTCGAGCTAGAATTCTTGACCAACA 3’), S. baynus PYK1 (5’ 
CAGATTGGTGGATCCATGTCTAGATTAGAAAGAT3’ & 5’ 
GTGGTGGTGCTCGAGTTAAACAGTAGAGACTTGCA3’) / PYK2 (5’ 
CAGATTGGTGGATCCATGCCAGAATCAAGACTGC3’ & 5’ 
GTGGTGGTGCTCGAGCTAAAACTCTTCACCAA3’), K. polysporus PYK (5’ 
CAGATTGGTGGATCCATGATGCAATCTAGATTAGG3’ & 5’ 
GTGGTGGTGCTCGAGTTAAACAATGGTAACTCTCA3’), K. lactis PYK (5’ 
CAGATTGGTGGATCCATGGAATCTAGATTAGGCTG 3’ & 5’ 
GTGGTGGTGCTCGAGTTAAACGGTCAAGACACGTA 3’), S. kluyveri PYK (5’ 
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CAGATTGGTGGATCCATGGAATCTAGACTAGGTTG3’ & 5’ 
GTGGTGGTGCTCGAGTTAGACGGTCAAGACACGCA 3’), and C. albicans PYK 
(5’CAGATTGGTGGATCCATGTCTCACTCATCTTTATC3’ & 5’ 
GTGGTGGTGCTCGAGTTAAGCTTGGACGATTCTAA3’). Each PYK cloned as BamHI-XhoI 
fragment (sites are underlined in the sequence of the primers) into the same plasmid.  
 
Expression and purification 
Pyruvate kinase was purified from E.coli DH5a containing ppSUMO-PYK vector. Overnight 
culture was transferred to fresh LB+Kan media and grown up to ~0.6 OD under 37°C. After 
lower the template to 25°C and continue grow for 0.5 hr, 1M IPTG was added to stimulate 
protein expression for 4 hr at 25°C. Cells were then collected and stored at -80°C. 
 
I largely simplified the purification of the enzyme. After breaking the cells in cold PBS solution 
by supersonic, the suspension were mixed with washed His-sumo tag beads (GLODBIO, CAT 
#H-310-5) at 4°C for 1 hr. The beads were then washed with PBS buffer for several times. A 
protein assay dye (Bio-Rad, CAT #500-0006) was used for quick protein detection. After no 
proteins were detected at the washed elution, the beads were transferred into a 2ml tube with 
addition of fresh PBS and restriction enzyme UlpI, and then incubated with mild shaking at 4°C 
overnight. The suspension will contain the PYK I wanted and can be store at -80°C.  
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Pyruvate kinase assay 
Pyruvate kinase activity was measured by a continuous assay coupled to lactate dehydrogenase 
(LDH) as previously described (44, 45). Activity was measured by the change in absorbance at 
340 due to oxidation of NADH by lactate dehydrogenase. Spectrophotometric measurements 
were made on either a Biotek machine or on a Cary 100 UV/VIS spectrophotometer with a 
cuvette holder thermocoupled at RT. Assay conditions were 0.05 M Imidazole-HCl buffer, pH 
7.6, containing 0.12 M potassium chloride and 0.062 M magnesium sulfate; 4.5 mM Adenosine 
diphosphate; 6.6mM NADH and ~10 unit/ml Lactate dehydrogenase (LDH). F1,6BP and PEP 
concentrations were varied in these assays. The reaction volume was 3 mL.  
 
Reactions were initiated by addition of between 0.01 and 0.04 ug of PYK. Steady-state kinetic 
rates were determined by measuring the slope of the tangent to the reaction progress curve. Stock 
substrate concentrations were verified and adjusted using an end point PYK assay by adding an 
excess of PYK and then measuring the total decrease in absorbance at 340 nm after 5 min. 
Pyruvate contamination in the PEP stock was measured by adding LDH to the assay buffer and 
measuring the total decrease in absorbance at 340 nm. The extinction coefficient of NADH used 
was 6.22 mM-1 cm-1. PYK concentrations were measured by a protein assay dye: Bradford 
(Bio-Rad, CAT #500-0006) with a spectrometer at 595nm. 1mg/ml BSA were used for 
Standards. 
 
Fermentation ratio measurement 
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Three independent clones for each strain are picked. The overnight cultures are transferred into 
2% YPD media and grow for 2 days. Collected cells are washed with distilled water and then 
grow in 10ml SDC medium of 20% glucose at a 150ml flask under 250 rpm at 30°C. The cell 
density starts as high as OD600=15 at the beginning. In these experiments, the cell concentration 
was prepared at a high level in order to rapidly evaluate the effects of the carbon materials on 
fermentation, and don’t have to consider about the effect of different growth rates for each 
species. Sample media are collected every 4hr for HPLC analysis. The OD600 is also monitored 
during the whole procedure.     
 
A Waters Associates liquid chromatograph, model ALC/GPC 244 equipped with a RID detector 
and an H-column (3.2 mm i.d. x 20 cm) are used to measure the concentration of glucose and 
ethanil. The mobile phase is 5% H2SO4. Operating conditions are flowrate: 0.6 ml/min, detector 
sensitivity: 8X, and chart speed: 0.4 in/min. 5 standards containing both glucose and ethanol 
have glucose concentrations ranging from 100, 50, 10, 1 to 0.5 g/L, and ethanol concentrations 
ranging from 50, 20, 10, 1 to 0.5 g/L.  
 
The fermentation ratio is measured by ethanol yield per glucose consumption, defined as 
(EtOH[t]-EtOH[0])/ (Glucose[0]-Glucose[t]), where t indicates the time points when glucose and 
ethanol are estimated. The higher the ratio is, the stronger the aerobic fermentation is. 
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Construction of T403E mutant strain 
The vector carrying T403E are kindly provided by B.L. Stoddard (46). One PCR fragment was 
amplified by using this plasmid as template and with two long primers: 
5’CTTGTTTCTATTTACAAGACACCAATCAAAACAAATAAAACATCATCACAATGTCTA
GATTAGAAAGATT3’ and 
5’TGGCTAGAAGAATAGGACGGAGTAGCACTTATCGTTTCTGATAAGAGGATCAATCCT
TTGAAATCTTGAA3’. This fragment which contains the latter part of S. cerevisiae PYK1 with 
T403E mutation and a following kanMX marker was then transferred into a PYK2 deleted 
BY4742 strain (MATa his3∆ leu2∆ lys2∆ ura3∆ pyk2∆). The transformed clones were picked 
and sequenced for the PYK1 gene. The ones with T403E mutation on PYK1 are the wanted 
mutants, and the ones with wild-type PYK1 are used as control.     
 
Oxygen consumption measurement 
Cells were grown to an OD600 of 1 in 2% YPD, spun down, and kept on ice. One hour before the 
measurements, cells were resuspended in SD–2% glucose and put on a shaker at 30°C for 1 hour. 
OD600 measurements and cell counts were performed immediately before putting cells in the 
oxygen sensing setup. The oxygen depletion rate was monitored by using a lab-built respirometer 
comprising a polarographic dissolved oxygen probe of Orion StarTM Series DO Meter (Thermo 
Scientific) in a glass syringe with constant agitation (47). Oxygen consumption rates were 
expressed as mg/ml O2 per minute per 1 X 107 cells. 
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FBA simulation 
I employ the iMM904 model for S. cerevisiae, which includes 904 genes, 1412 reactions, and 
1212 metabolites to see how pyruvate consumption in different pathways varies depending on 
glucose or pyruvate uptake. A minimum of 0.1 mmol/(gDW h) glucose is consumed with 
increasing amounts of either pyruvate or glucose uptake, extending to a maximum experimental 
uptake for each metabolite.   
 
Library Construction and Data Analysis for Illumina-Based Strand-Specific Multiplex 
RNA-Seq 
Two independent clones of each strain are cultured in 2% YPD until OD600 reached 0.5. RNA 
exaction with TRIzol was then performed (48) and the pellets were re-suspended in 0.05–0.3 mL 
RNA-secureTM solution (Ambion, CA) based on the pellet size and heated at 60°C for 10 minutes 
before stored at -80°C in a freezer. 
 
I used a low-cost and robust protocol to produce Illumina-compatible (HiSeq2000 platform) 
RNA-seq libraries (49). The starting total RNA concentration was measured using NanoDrop 
(Thermal Scientific, DE) and 15 ug of total RNA was used for mRNA purification. After heated 
on 65°C for 2 minutes, the RNA samples were mixed with 30 uL of Dynabeads (Invitrogen, CA) 
in binding buffer (Tris-HCl 20 mM, LiCl 1 M, EDTA 2 mM) and incubated at room temperature 
with mild agitation for 10 minutes. The beads were then washed twice with 150 uL of washing 
buffer (Tris-HCl 10 mM, LiCl 0.15 M, EDTA 2 mM), and eluted with 50 uL elution buffer 
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(Tris-HCl 10 mM) at 80°C on an incubator/shaker for 2 min with mild agitation. The 
concentration of mRNA was immediately measured with 1 uL of sample in a QubitH 
Fluorometer (Invitrogen, CA). 30 ng of mRNA was used for cDNA synthesis. 4 uL of spiking 
RNA mix and 4uL of 5 x first strand buffer (Invitrogen, CA) were then added to each mRNA 
sample. The mixture was incubated at 94°C for 4.5 minutes to fragment RNA and then 
immediately chilled on ice before the next step. 
 
The 12ul fragmented mRNA, 0.5 uL of Random primer (Invitrogen, CA), 0.75 uL of 
SupeRase-In (Ambion, CA) and 1 uL of DTT (100 mM) were heated at 65°C for 3 minutes. 
Then 4 uL of water, 1 uL of DTT (100 mM), 0.1 uL of dNTPs (25 mM), 0.5 uL of SupeRAse-In 
and 0.5 uL of Superscript II (Invitrogen, CA) were added and incubated in a PCR machine using 
the following conditions: 25°C for 10 minutes, 42°C for 50 minutes, 70°C for 15 minutes and a 
4°C hold. The resulting RNA/cDNA double-stranded hybrid was then purified with AMPure XP 
beads and added to 2 uL of 10x NEB buffer-2 (NEB, MA), 1 uL of dUTP mix (10 mM dATP, 
dCTP, dGTP and 20 mM dUTP), 0.5 uL of RNAse H (2 U/mL), 1 uL of DNA polymerase I and 
0.5 uL of DTT(100 mM). The mixture was incubated at 16°C for 2.5 hours. The resulting 
dUTP-marked dsDNA was again purified with AMPure XP beads. 
 
The purified dsDNA (16 uL) was mixed with 2 uL of 10xEnd Repair Buffer (Enzymatics, MA), 
1 uL of dNTP mix (10 mM each) and 1 uL of End Repair enzyme mix (Enzymatics, MA). The 
mixture was incubated in a PCR machine for 30 minutes at 20°C and purified with AMPure XP 
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beads. It was then added to 2 uL of 10x NEB buffer-2 (NEB, MA), 1 uL of 10 mM dATP mix, 
and 0.5 uL of Klenow 3’–5’ exo- (Enzymatics, MA). The mixture was incubated in a PCR 
machine at 37°C for 30 minutes and then purified. The resulting end-repaired and dA-tailed 
product was then added to a mixture of 1 uL of indexed adaptor with 1ul T4 DNA ligase 
(Enzymatics, MA) and 2 x ligation buffer. Half of the ligation solution was mixed with 12 uL of 
‘‘12p XP’’ beads and incubated at RT for 6 minutes. The supernatant was then mixed with 12 uL 
of AMPure XP beads and 5 uL of 40% of PEG8000 and eluted with 10 uL of nuclease-free water.  
 
The size-selected dsDNA product was mixed with 1 uL of uracil DNA glycosylase (Enzymatics, 
MA) and incubated at 37°C for 30 minutes. The mixture was then added to 2 uL of Illumina PE 
primers (5 mM each), 6 uL of 5xPhusion HF buffer, 1 uL of 10 mM dNTP, 1 uL of Phusion Hot 
Start 2 High-Fidelity DNA Polymerase (NEB, MA) and 4.5 uL of water. The PCR mix was 
incubated with a programmed cycle as following: 94°C for 30 sec, 8-16 cycles (depend on final 
concentration) of 98°C, for 10 sec, 65°C for 30 sec, 72°C for 30 sec; 72°C for 5 min followed by 
a hold at 4°C. The final product was purified with 43 uL of AMPure XP beads and eluted with 12 
uL of EB buffer. The concentration of PCR products was measured using the dsDNA-HS 
protocol on the Qubit Fluorometer. Equal quantities of libraries (approximately 5 ng per sample) 
with different indices were mixed and stored in -80°C freezer. The illumine sequencing was 
down in genomics resources core facility at WCMC with the platform of HiSeq2000 58 cycles.  
 
Life span measurement  
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Streak yeast onto YPD plates and incubate for 2 days at 30°C. Pick a few colonies (four to five) 
into 1–2 mL of 2% SDC medium and grow overnight. Dilute the overnight culture to an initial 
density as OD600 of 0.1–0.2 in 10–50 mL of SDC. Incubate at 30°C in flasks with shaking at 220 
rpm. Each strain has three replicates.  
 
After 3 days, start monitoring survival by measuring the ability of an individual yeast 
cell/organism to form a colony. Cultures are serially diluted to reach a 1:105 dilution in sterile 
distilled water and 100 uL of the same dilution are plated in duplicate onto two YPD plates. The 
forming clones are counted after 2–3 days. The maximum number of clones usually at day 3 is 
considered to be the initial survival (100% survival) and is used to determine the age-dependent 
percent survival. Monitor the number of clones every 48 hr by adjusting the dilution factor and 
the volume plated according to the mortality rate. Continue until survival reaches 1% to record a 
time value that approximates the maximum survival time (50).  
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CHAPTER FOUR 
 
 
 
 
Duplication of the target of rapamycin (TOR) gene contributes to the fermentation life style 
in yeast 
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4. 1. Summary 
The budding yeast Saccharomyces cerevisiae and its relatives predominantly ferment glucose 
into ethanol even in the presence of oxygen. The underlying genetic basis of the evolution of 
aerobic fermentation remains unclear. There are growing evidences to support that the target of 
rapamycin (TOR) might be involved in the regulation of energy metabolism, the role of TOR 
gene in the evolution of aerobic fermentation has not been fully explored. In this study, I 
revealed a positive correlation between the copy number of TOR genes and the strength of 
aerobic fermentation, suggesting that TOR gene duplication has facilitated the evolution of 
aerobic fermentation. I further doubled the TOR gene in a Crabtree-negative yeast K.lactis to 
mimic the TOR gene duplication during yeast history, and observed that the fermentation ratio in 
this mutant is significantly increased. My results not only provide evidence to support that TOR 
gene duplication contributes greatly to the evolution of fermentation life style in yeast, but also 
shed light on the causal correlation between dysregulation of mTOR signaling and Warburg 
effect in cancer cells.  
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4. 2. Introduction 
Aerobic fermentation is a glucose metabolic pathway that predominantly ferments glucose to 
ethanol even in the presence of oxygen. The hemiascomycete yeasts that prefer aerobic 
fermentation are called Crabtree-positive yeasts (1); these include Saccharomyces cerevisiae and 
its relatives. In contrast, the Crabtree-negative yeasts, such as the dairy yeast Kluyveromyces 
lactis, prefer to completely oxidize glucose to CO2 through the mitochondrial respiration 
pathway for maximum energy and biomass gain (2). The fission yeast Schizosaccharomyces 
pombe, which diverged from the hemiascomycete lineage around 330–420 Ma (3), also prefers 
aerobic fermentation (4). Therefore, it is believed that aerobic fermentation has evolved 
independently in the S. cerevisiae lineage and in the S. pombe lineage.  
 
Many studies have shed light on the underlying genetic basis for the origin and evolution of 
aerobic fermentation, but different explanations were proposed (5-10). Several studies have 
shown that the target of rapamycin (TOR) might be involved in the regulation of energy 
metabolism (11-15). TOR is an essential ser/thr protein kinase that functions in two distinct 
multiprotein complexes, TOR complex 1 and 2. The structure and functions of these complexes 
have been conserved from yeast to man. TOR complex 1 is inhibited by rapamycin and is 
thought to couple growth cues to cellular metabolism; TOR complex 2 is not inhibited by 
rapamycin and appears to regulate spatial aspects of growth such as cell polarity (16-18).  
 
Tumor cell energy metabolism shares some common features with yeast metabolism, as tumors 
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display an enhanced glycolytic activity and oxidative phosphorylation downregulation (Warburg 
effect) (19-22). It is also widely accepted that hyperactivation of mTOR signaling is one of the 
most frequent occurrences in human cancer (23). However, the regulatory mechanism of 
Warburg effect is still obscure. On the other hand, the underlying mechanisms that cause 
tumorigenesis as a result of activated mTOR remain largely unknown. Several recent studies 
indicate a role of mTOR signaling on direct control of energy metabolism in cancer cell, yet meet 
in huge conflicts. While some researchers found that inhibiting the rapamycin-sensitive subset of 
mTOR functions in cancer cells enhanced aerobic glycolysis and decreased uncoupled 
mitochondrial respiration (24, 25), other studies provided evidences to support that mTOR was a 
major positive regulator of the Warburg effect (26-29). Since metabolism regulations are 
complex in different kinds of cancer cells, yeasts may serve as a simple model to clarify this 
mechanism given the common features and conserved pathways with cancer cells.  
 
Studies in S. cerevisiae showed that reduced TOR signaling was accompanied by increased 
respiration and upregulation of mitochondrial gene expression (11), which suggests a possible 
role of TOR signaling on the regulation of energy metabolism. However, in-depth investigation 
of the evolutionary history of TOR genes and their role in the evolution of aerobic fermentation 
in yeasts has not been reported so far. In our study, I firstly identified an interesting association 
between the copy number of TOR genes and the fermentation ability in yeast species. In view of 
this fact, mimicking duplication event of TOR gene in pre-WGD yeast species such as K.latics 
will likely provide new insights into the evolution of yeast aerobic fermentation, which may also 
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shed lights on the question whether and how the change of TOR signaling lead to Warburg effect 
in cancer cells.   
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4. 3. Results 
4.3.1. Distribution of copy number of TOR genes in yeast phylogenetic tree 
To study the evolution of the TOR gene, I constructed a phylogenetic tree using the homologous 
sequences from 18 yeast species. I found that almost all the post-WGD yeast species possess two 
copies of TOR gene while the pre-WGD yeast species only have one (Figure 4.1A). The WGD 
event has been proposed to have led to the evolution of fermentation lifestyle in yeast (30-33) 
which makes the post-WGD species better fermenters compared to those pre-WGD ones in most 
cases (2), however, it remains unclear how many and which WGD genes have the most 
contribution. Given the evidences that TOR gene is involved in controlling energy metabolism 
(11-15), I want to ask if TOR gene duplication from WGD plays an important role in the 
development of fermentation ability.  
 
I found one post-WGD yeast K. polysporus that cannot carry out efficient fermentation (34) just 
retains one TOR gene in its genome, with the other one lost during the evolution (Figure 4.1A). 
On the other hand, the fission yeast, S. pombe, which diverged from the ancestor of S. cerevisiae 
much earlier than the WGD, can conduct efficient aerobic fermentation, and as well has two 
TOR genes that are derived from an independent gene duplication event (Figure 4.1B). These 
correlations suggest that the TOR gene duplication may have facilitated the evolution of aerobic 
fermentation.  
 
I also found three large-scale independent duplications of ribosomal protein (RP) gene occurred 
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Figure 4.1. A. Number of tor genes in clade Saccharomycotina. Arrow indicates when WGD 
occurred. Numbers in parenthesis are number of tor genes in each species. B. Phylogenetic tree 
of two tor genes in S. cerevisiae and S. pombe shows independent tor gene duplication. S. 
cerevisiae tor genes: YJR066W and YKL203C; S. pombe tor genes: SPBC216.07c and 
SPBC30D10.10c.  
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during fungi evolution. One is in the filamentous fungus Rhizopus oryzae, which is an obligate 
aerobe as well as a good fermenter that is often used for industrial production of L-(+)-lactic acid 
(35). Another two RP dupications events happened in the common ancestor of S. pombe and S. 
japonicus, and in the common ancestor of Saccharomyces sensu stricto species complex after the 
WGD (Figure 4.2). This duplication pattern of RP genes is quite related to aerobic fermentation 
and also consistent to that of TOR gene duplication. Since TOR regulates ribosome biosynthesis 
(16), this result indicates that the TOR signaling is enhanced coupling with TOR gene 
duplication, which further contributes to the development of aerobic fermentation.  
 
4.3.2. Double TOR gene in the genome of K.lactis 
In order to test our hypothesis that TOR gene duplication may contribute to the evolution of 
aerobic fermentation, I choose K.lactis as a good experimental model since K.lactis is a 
pre-WGD species with only one TOR gene in its genome and cannot perform aerobic 
fermentation as well as budding yeast. Therefore, Doubling TOR gene in its genome would 
mimic the TOR gene duplication event in the yeast ancestor of budding yeast.  
 
As TOR gene is involved in the control of cellular growth and proliferation (16), I do observe 
that the doubled TOR mutant grows faster than its control (Figure 4.3). The average doubling 
time for the doubled TOR mutant is 4.87 hours in YPD media, compared to 5.52 hours for the 
control (P = 0.00089). In addition, I also find that the doubled TOR mutant is more resistant to 
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Figure 4.2. Duplication pattern of ribosomal protein genes in all sequenced fungi species. Each 
row represents a RP gene and each column represents a fungi species. Green indicates one copy 
of RP gene, while red indicates more than one copy. Black indicates that no orthologous gene 
was found in that species. Three large scale independent RP gene duplications occurred during 
fungi evolution in Rhizopus oryzae (left red column), in the common ancestor of S. pombe and S. 
japonicus (middle red columns) and the common ancestor of Saccharomyces sensu stricto 
species complex (right red columns) from WGD. The phylogenetic relationship for all fungi 
species is shown at the top of the figure.  
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Figure 4.3. The growth curves of the doubled TOR mutant and its control in YPD media. A. 
OD600 VS time. B. Natural log of OD600 VS time. The maximum growth rate (Max V) is derived 
from Figure 4.3 B. The doubling time is calculated by [ln (2) / Max V] * 60. Each data has three 
replicates. Here shows the representative growth curve. The mean doubling time for K. Lactic 
control is 5.52 hr, and for K. Lactic doubled TOR mutant is 4.87 hr, the P value is 0.00089.  
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rapamycin than control (Figure 4.4), as the normalized doubling time of rapamycin treatment is 
3.35 hours for the doubled TOR mutant, compared to 4.34 hours for the control (P = 2.24 x 10-6). 
Therefore, both results above suggested that the doubled TOR mutant has increased TOR activity. 
The gene expression level change of TOR gene in the doubled TOR mutant will be examined in 
RNA-seq data.  
 
4.3.3. The fermentation ability of the doubled TOR mutant and wild-type    
After investigating the metabolites by HPLC in growing media, we found that the doubled TOR 
mutant consumed much more glucose and had a significantly higher production of ethanol as 
compared to wild-type (Figure 4.5A). This result is consistent with the fact that the doubled TOR 
mutant grows faster (Figure 4.3). The Fermentation ratio of the doubled TOR mutant is also 
shown to be significantly higher than that of wild-type (Figure 4.5B), which proves our 
hypothesis that TOR gene duplication plays an important role in contributing to the evolution of 
aerobic fermentation. However, we didn’t find significant difference in oxygen consumption 
between the doubled TOR mutant and its control (Figure 4.5C), which may suggest that 
increased TOR activity affects cellular energy metabolism not by repressing respiration but 
rather by enhancing fermentation. 
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Figure 4.4. The sensitivity to rapamycin of the doubled TOR mutant and its control. (A) Growth 
curve of the doubled TOR mutant and its control treated with or without 0.05uM rapamycin. 
(OD600 VS time) (B) Converted from Figure 4.4 A. Natural log of OD600 VS time. The maximum 
growth rate (Max V) is derived from Figure 4.4 B. The doubling time is calculated by [ln (2) / 
Max V] * 60. Each data has three replicates. Here shows the representative growth curve. The 
mean doubling time (DT) for K. Lactic control is 5.52 hr without rapamycin, and is 23.99 hr with 
0.05uM rapamycin; the mean DT for K. Lactic doubled TOR mutant is 4.87 hr without 
rapamycin, and is 16.31 hr with 0.05uM rapamycin. The normalized DT of rapamycin treatment 
is calculated by DT(rap)/DT(w.o. rap). For K. Lactic control, this value is 4.34 hr, and for K. 
Lactic doubled TOR mutant, it’s 3.35 hr, P = 2.24 x 10-6. 
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Figure 4.5. The doubled TOR mutant has higher fermentation ability compared with the control. 
(A) The glucose, ethanol concentrations during aerobic batch cultivation of wild-type strain and 
doubled TOR mutant. (B) Fermentation ratio of wild-type strain and doubled TOR mutant during 
aerobic batch culture. (C) The oxygen consumption (mg/ml/107) of wild-type strain and doubled 
TOR mutant. 
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4.3.4. Expression profiling of doubled TOR mutant by RNA-seq 
In order to better confirm and understand the mechanism in doubled TOR mutant how the 
fermentation ability is enhanced, we plan to employ RNA-seq technique to compare the 
transcriptome profiling of this mutant with its control strain. The mRNA libraries are already 
constructed and waiting for HiSeq2000 sequencing.  
 
4.3.5. The life span of the doubled TOR mutant and wild-type 
The TOR pathway appears to have a conserved role in regulating life span. Although it remains 
unclear precisely which aspects of TOR contribute most significantly to aging and life span 
regulation, some studies have documented that there might be complex relationships between 
TOR signaling, mitochondrial function and yeast chronological life span (CLS), as reduced TOR 
signaling may extend CLS via increased respiration and up-regulation of mitochondrial gene 
expression (11, 36-38). Since we uncovered energy metabolism change in doubled TOR mutant, 
we are interested to further test whether the CLS of this mutant is also affected.  
 
Our result showed that the doubled TOR mutant didn’t have significant difference in life span 
compared with control (Figure 4.6). Although we observed increased fermentation in the doubled 
TOR mutant (Figure 4.5B), its oxygen consumption was similar with that in wild-type (Figure 
4.5C) which suggested that respiration might not be affected in this mutant. Previous studies 
indicate that CLS extension in yeast with reduced TOR signaling requires increased 
mitochondrial respiration (11, 37), which may explain our data. However, we still found an  
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Figure 4.6 Chronological life span analysis of doubled TOR mutant and the control. Each data 
has two replicates. Here shows the representative growth curve. Average lifespans: K.lac wt, 21.6 
days; K.lac doubled TOR mutant, 22.5 days. P-value is 0.85.  
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interesting difference in life span patterns of these two strains (Figure 4.6), as a sudden drop of 
survival ratio occurred much earlier in the doubled TOR mutant than in the wild-type strain. A 
possible explanation could be the faster consumption of glucose in the doubled TOR strain 
(Figure 4.5A), which makes this mutant confront starvation and other stressful conditions earlier.  
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4. 4. Discussion 
In the present study, we have shown that doubling TOR gene in K.lactis could improve its 
fermentation ability, which provides strong evidence to support that the duplication of TOR gene 
contributes greatly to the evolution of aerobic fermentation in yeast history. S. cerevisiae and S. 
pombe, the two aerobic fermentation lineages, use TOR gene duplication as a common strategy 
to develop their fermentation life style, and the subsequent functional and regulatory divergence 
of TOR gene after gene duplication may help better adaptation to the new life style. In contrast, 
yeasts which cannot ferment very well only keep one TOR gene in the genome, even by gene 
loss such as K. polysporus. However, it seems that these yeasts still hold the potential to increase 
fermentation, as doubling TOR gene in K.lactis can clearly show the effect (Figure 4.5B). Yet 
this may lead to negative consequences on affecting the yeast’s fitness under certain conditions, 
since the K.lactis doubled TOR mutant has a much earlier sharp decrease on survival rate 
compared with control (Figure 4.6). One possible reason could be the non-ferment yeasts, like 
K.lactis, don’t have a good adaption mechanism for increased fermentation. Therefore, we 
proposed that TOR gene duplication might be one of the most important factors to initiate the 
evolution of aerobic fermentation by dosage effect, yet the well developed fermentation life style 
may need further subfunctionalization of TOR duplicates and coordination with other genes on a 
global way.  
 
In addition, our study also indicates a direct role of TOR signaling on regulating aerobic 
fermentation. This result is supported by several recent works in mammalian cells. Qian Sun et al. 
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(26) found that mTOR was a major positive regulator of the Warburg effect, and identified 
PKM2 as a critical glycolytic enzyme in oncogenic mTOR-induced Warburg effect. Another 
study reported that lactate dehydrogenase B (LDHB), a critical enzymatic activator of glycolysis, 
was a downstream target of mTOR that was critical for oncogenic mTOR-mediated 
tumorigenesis (27). Moreover, another research group proposed that elevated mTOR signaling in 
cancer cells could increase phospholipase D (PLD) activity, which is critical for the metabolic 
shift to aerobic glycolysis (28). All these studies are in good agreement with our results, which 
suggests our doubled TOR mutant could be served as a good model to study the detail 
mechanism how TOR signaling controls the highly glycolytic phenotype, thus shed lights on 
developing new therapeutic targets in cancers.  
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4. 5. Experimental Procedures and Methods 
Phylogenetic tree of two TOR genes in S. cerevisiae and S. pombe 
The sequences of two TOR genes in S. cerevisiae (YJR066W and YKL203C) and in S. pombe 
(SPBC216.07c and SPBC30D10.10c) are downloaded from NCBI. The ortholog of TOR gene in 
Cryptococcus neoformans is used as outgroup. Tree was constructed using neighbor-joining 
method in software package MEGA. 
 
Phylogenetic tree of all sequenced fungi species 
Orthologs among fungi species were downloaded from InParanoid and then checked manually. A 
random set of 10 one-to-one orthologs in all species were used to reconstruct the tree. Muscle 
was used to conduct multiple sequence alignment and ClustalW was used to reconstruct the tree 
based on protein distances. The bootstrap values for all nodes are larger than 50%. 
 
Cloning of K.lactic TOR gene 
K. lactis wild type strain (PM6-7A) was kindly provided by X. J. Chen (The Australian National 
University, Australia). One ~9 Kbp fragment containing the whole coding region of the K. lactis 
TOR gene as well as its 1Kbp 5’ end UTR and ~300 bp 3’ end UTR was cloned into PRS406 
vector with URA3 marker by a three fragment amplification method. Three short fragments 
(~3000bp each) were amplified by PrimeStar PCR system (Takara Bio), using K. lactis genomic 
DNA as the template.  Each fragment was digested by corresponding digestion enzymes and 
then sub-cloned into PRS406 in sequence. Each sub-clone will be confirmed by DNA sequencing 
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before moving on to the next sub-cloning. The primers for the first short fragment were 
5’CCCGGGCTCGAGCGTGGCAATGGATTATGAAA3’ and 5’GTTTCATAGGGGTAGGGG3’, 
and the fragment would be digested by XhoI and BamHI. The second short fragment was 
amplified by primers 5’TGTACTATCTGGTGAGAAG3’ and 5’ TTTCATATCTTGTTTAGGCT 
3’, with restriction sites BamHI and SpeI. The third fragment has the primers of 
5’TTCTAAAGGTACGGTCACTA3’ and 5’ AATTGCGGCCGCGGTATCACCAGAACGAACA 
3’, the corresponding restriction enzymes are SpeI and NotI.  
 
Constructing doubled TOR mutant 
SpeI was used to cut in the middle of TOR gene, which would result in a linear PRS406-TOR. 
This linear DNA was transformed into K. lactis by Lithium Acetate method. Stable ura3+ strains 
were selected and confirmed as doubled TOR mutant. Two sets of confirmation primers are 
5’TGTGAGAACGTAATGATGGT3’, 5’ ATTGGTGTAATTGAGCATTT3’ and 5’ 
AAATCGGCAAAATCCCTTAT3’, 5’ ACGCCTGGTATCTTTATAGT3’, respectively. In order 
to make a perfect control for the doubled TOR mutant, we inserted PRS406 after TOR gene into 
the genome, with a similar strategy above, just by replacing the ~9 Kbp long DNA with a 
fragment of 3’ UTR of TOR gene in PRS406 cloning.  
 
Growth curve 
Three independent clones for either control or doubled TOR strains were picked and grew in 
YPD media with a start OD600 = 0.1.  The growth curve was measured by Bioteck machine.  
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Fermentation ratio measurement 
Detail procedures described in 3.5. 
 
Oxygen consumption measurement 
Detail procedures described in 3.5. 
 
Library Construction for Illumina-Based Strand-Specific Multiplex RNA-Seq 
Detail procedures described in 3.5. 
 
Life span measurement  
Detail procedures described in 3.5. 
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